Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Med Sci Monit ; 23: 2029-2034, 2017 Apr 27.
Article in English | MEDLINE | ID: mdl-28448477

ABSTRACT

BACKGROUND Acute diarrhea is the second most common cause of morbidity and mortality worldwide, especially in children aged ≤3 years. Some drugs (e.g., the mucoprotector gelatin tannate) plus a reduced osmolality oral rehydration solution (ORS) may effectively reduce symptom duration and severity. The current trial was therefore designed to assess the efficacy and safety of gelatin tannate in pediatric patients with acute diarrhea. MATERIAL AND METHODS This was a randomized, controlled, double-blind, parallel-group, single-center study comparing gelatin tannate plus ORS (103 patients) with ORS plus placebo (100 patients) in children aged 3 months to 12 years with infectious or noninfectious acute diarrhea. Details about stool consistency and total time to resolution of diarrhea comprised the primary study endpoints. Secondary study endpoints included symptoms of diarrhea at 12, 24, 36, 48, and 72 hours after the first dose of study medication. RESULTS From 12 hours onwards, the incidence of watery stools was significantly lower in the gelatin tannate group than in the ORS group (at 12 hours: 59.2% vs. 77.0%; p=0.01). The same was true for stool frequency (at 12 hours: mean 2 vs. 3 stool productions in the previous 12 hours; p<0.01). At all timepoints during the study, the proportion of patients with Stool Decrease Index improvement was significantly greater (p<0.01) in the gelatin tannate group than in the placebo group (at 12 hours: 66.6% vs. 33.3%; p<0.01). CONCLUSIONS Gelatin tannate plus ORS is an effective and safe option for the treatment of acute diarrhea in children. Significant symptom relief is evident 12 hours after starting treatment.


Subject(s)
Diarrhea/drug therapy , Gelatin/therapeutic use , Tannins/therapeutic use , Acute Disease , Child , Child, Preschool , Double-Blind Method , Feces , Female , Fluid Therapy/methods , Humans , Infant , Male , Osmolar Concentration , Treatment Outcome
2.
J Clin Res Pediatr Endocrinol ; 3(3): 144-8, 2011.
Article in English | MEDLINE | ID: mdl-21911328

ABSTRACT

OBJECTIVE: Infants of diabetic mothers (IDM) are considered as a risk group for atherosclerosis. Increased aortic intima-media thickness has been reported in IDM. The purpose of this study was to assess carotid artery intima-media thickness (CA-IMT), left ventricular mass index (LVMI) and atherosclerotic risk factors in IDM. METHODS: Thirty IDM and 25 healthy controls were included in the study. Of these infants, 14 were appropriate-for-gestational age (AGA) and 16 were large-for-gestational age (LGA). CA-IMT and LVMI were obtained by M-mode echocardiographic examination. The relationship between parameters of atherosclerosis and echocardiographic measurements was assessed by Pearson's correlation analysis. RESULTS: LVMI was higher in LGA IDM when compared to AGA IDM and controls. CA-IMT was not significantly different between the groups and was also not related to atherosclerotic risk factors. Serum lipid and insulin levels were higher in LGA IDM when compared with AGA IDM and controls. There were no correlations between CA-IMT, LVMI and atherosclerotic risk factors. CONCLUSIONS: In contrast to previous reports indicating an increase in CA-IMT in IDM, no differences were found between IDM and controls in this study. Our results indicate that macrosomic IDM are prone to hypertrophic cardiomyopathy but not to atherosclerotic changes in the blood vessels.


Subject(s)
Atherosclerosis/etiology , Carotid Intima-Media Thickness , Heart/anatomy & histology , Pregnancy Complications, Cardiovascular/pathology , Pregnancy in Diabetics/pathology , Atherosclerosis/embryology , Birth Weight/physiology , Blood Glucose/metabolism , C-Peptide/blood , Case-Control Studies , Cholesterol/blood , Female , Fetal Blood/chemistry , Heart Ventricles/anatomy & histology , Heart Ventricles/diagnostic imaging , Humans , Infant, Newborn , Insulin/blood , Pregnancy , Pregnancy Complications, Cardiovascular/blood , Pregnancy Complications, Cardiovascular/diagnostic imaging , Pregnancy Complications, Cardiovascular/physiopathology , Pregnancy in Diabetics/blood , Pregnancy in Diabetics/diagnostic imaging , Prospective Studies , Statistics, Nonparametric , Triglycerides/blood , Ultrasonography, Doppler
3.
Brain Dev ; 32(7): 595-7, 2010 Aug.
Article in English | MEDLINE | ID: mdl-19765926

ABSTRACT

Syringomyelia (SM) is a disorder in which a cyst forms within the spinal cord. This cyst, called a syrinx, expands and elongates over time, destroying the center of the cord. Horner syndrome is an infrequent illness caused by a lesion of the cervical sympathetic nerve fiber. Its clinical features are facial anhidrosis, ptosis, miosis, and hypochromia iridis of the affected side. A full-term male newborn infant was admitted with weakness in bilateral upper extremities and narrowing of the palpebral fissure on the right side. Ophthalmologic examination revealed a smaller right pupil. Muscle power in bilateral upper limbs was 1/5. Chest X-ray and cranial magnetic resonance imaging were normal. Magnetic resonance imaging of the cervicothoracic spine showed SM at C4-T2 level. Electromyographic examination revealed bilateral brachial plexus palsy. The diagnosis was of brachial plexus palsy and congenital Horner syndrome due to congenital cervicothoracic SM. According to our best knowledge, this association has not been reported in the literature.


Subject(s)
Brachial Plexus Neuropathies/etiology , Horner Syndrome/congenital , Horner Syndrome/etiology , Syringomyelia/congenital , Syringomyelia/complications , Brachial Plexus Neuropathies/physiopathology , Cervical Vertebrae , Female , Horner Syndrome/physiopathology , Humans , Infant, Newborn , Male , Syringomyelia/pathology , Thoracic Vertebrae
SELECTION OF CITATIONS
SEARCH DETAIL